SILVER SPRING, Md., Feb. 20 /PRNewswire-FirstCall/ -- United Therapeutics
Corporation (Nasdaq: UTHR) today announced financial results for the fourth
quarter and year ended December 31, 2006. "We...
SILVER SPRING, Md., Feb. 13 /PRNewswire-FirstCall/ -- United Therapeutics
Corporation (Nasdaq: UTHR) announced today that it will release its 2006
fourth quarter and annual financial results before...
SILVER SPRING, Md. and SATELLITE BEACH, Fla., Dec. 12
/PRNewswire-FirstCall/ -- Lung Rx, Inc., a wholly-owned subsidiary of United
Therapeutics Corporation (Nasdaq: UTHR), announced that its...
SILVER SPRING, Md., Nov. 13 /PRNewswire/ -- United Therapeutics Corporation
(Nasdaq: UTHR) announced today that its wholly owned subsidiary Unither Pharma,
Inc. has settled all patent litigation with...
SILVER SPRING, Md., Oct. 31 /PRNewswire-FirstCall/ -- United Therapeutics
Corporation (Nasdaq: UTHR) today announced financial results for the quarter
ended September 30, 2006. "We are pleased to...
SILVER SPRING, Md., Oct. 24 /PRNewswire-FirstCall/ -- United Therapeutics
Corporation (Nasdaq: UTHR) today announced the pricing of $210 million
principal amount of Convertible Senior Notes due 2011...
SILVER SPRING, Md., Aug. 1 /PRNewswire-FirstCall/ -- United Therapeutics
Corporation (Nasdaq: UTHR) today announced financial results for the quarter
ended June 30, 2006. "We are pleased to...